MYGN share price will go up once the Supreme Court ruling is done
If the Supreme Court ruling is against MYGN, price might go down initially. However, given the case won’t have any material impact on the company because the litigation affects only a fraction of its patent rights, share price will come back once people are realizing earning will not be impacted. If good news comes, price will be soaring,
80 percent of their revenue is derived from these 2 patents. This thing is gonna tank if they lose. It has held up pretty well given the uncertainty of this case. Credit Suisse analysis estimates 30 bucks a share if they win, 20 bucks if they lose.
Do you have faulty memory? Several of us spent a lot of time explaining to you that just because the patents touch on 80% of their revenue, it's not true that Myriad gets much (or really, any) of their revenue from the patents. You seemed to understand, if somewhat grumpily, at the end.
For everyone else: Myriad does BRCA1 &2 mutation testing better, faster and cheaper than anyone else can, and has a lot of expensive infrastructure to turn that ability into a business. Patents or no, they own the business. They COULD lose it, but not over this.